ISRCTN90702227
Active, not recruiting
Phase 1
Phase I trial: Ocular Technology Group International[The full scientific title will be published within 30 months after the end of the trial]
Overview
- Phase
- Phase 1
- Status
- Active, not recruiting
- Enrollment
- 20
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Exclusion Criteria
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
Investigators
Similar Trials
Active, not recruiting
Phase 1
Phase I trial: Ocular Technology Group International CV23-08The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.Not ApplicableISRCTN66819383CooperVision International Ltd40
Recruiting
Phase 1
ROH-001 ophthalmic solution phase I clinical trial -Single and multiple dose studyHealthy volunteerJPRN-jRCT2051230128Mantani Tomomi48
Active, not recruiting
Phase 1
A Phase II, pilot clinical trial to evaluate the effects of atorvastatin on Graves' Orbitopathy (GO) in hypercholesterolemic patients with moderate-to-severe and active GO subjected to intravenous glucocorticoid therapy.Graves’ orbitopathy is a disabling and disfiguring disease affecting the eyes observed in approximately 25-30% of patients with Graves’ disease. Its clinical manifestations include exophthalmos, inflammatory signs and symptoms, diplopia, and in most severe cases sight impairment.MedDRA version: 20.0Level: PTClassification code 10004161Term: Basedow's diseaseSystem Organ Class: 10014698 - Endocrine disordersTherapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2018-001317-33-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA88
Completed
Not Applicable
Retinal Artery Study in participants with obstructive sleep apnoea treated with continuous positive airway pressureEndothelial functionSleep ApnoeaCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemRespiratory - Sleep apnoeaACTRN12610000311055Austin Health Department of Cardiology and Institute for Breathing and Sleep30
Completed
Not Applicable
Eye movement desensitization and reprocessing therapy as video-conference psychotherapyA memory of an adverse life event that causes a disturbing memory trace measured by Subjective Unit of Distress (SUD)Mental and Behavioural DisordersISRCTN12099530niversity of Worcester24